secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0001493152-25-009684
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Oncocyte promotes James Liu to VP Accounting, Controller, Treasurer; grants RSUs to executives
--------------------------------------------------------------------------------

- James Liu promoted to VP Accounting, Controller, Treasurer and Principal Accounting Officer, effective March 10, 2025; salary $225,000.
- CEO Joshua Riggs annual salary raised to $420,000 from $400,000; CFO Andrea James to $341,250 from $325,000.
- One-time RSU grants: CEO $600k (max 200k shares), CFO $360k (max 120k), CSO $360k (max 120k), vesting over 4 years.
- CFO Andrea James receives $25,000 one-time bonus in cash or RSUs at her discretion.
- James Liu also receives $60k in RSUs (3-year vest) and 10,000 options (4-year vest).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315225009684/0001493152-25-009684-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315225009684/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009684

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer